Canada markets open in 8 hours 24 minutes

Yonghe Medical Group Co., Ltd. (L97.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.1210+0.0110 (+10.00%)
At close: 08:05AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 79.71M
Enterprise Value 143.08M
Trailing P/E 35.19
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.24
Price/Book (mrq)0.48
Enterprise Value/Revenue 0.08
Enterprise Value/EBITDA -0.73

Trading Information

Stock Price History

Beta (5Y Monthly) 0.30
52-Week Change 3-84.78%
S&P500 52-Week Change 322.38%
52 Week High 30.8800
52 Week Low 30.0905
50-Day Moving Average 30.1176
200-Day Moving Average 30.2741

Share Statistics

Avg Vol (3 month) 314
Avg Vol (10 day) 3N/A
Shares Outstanding 5526.2M
Implied Shares Outstanding 6658.72M
Float 8115.8M
% Held by Insiders 156.61%
% Held by Institutions 118.85%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 30, 2022
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -30.74%
Operating Margin (ttm)-24.70%

Management Effectiveness

Return on Assets (ttm)-10.65%
Return on Equity (ttm)-43.26%

Income Statement

Revenue (ttm)1.78B
Revenue Per Share (ttm)3.58
Quarterly Revenue Growth (yoy)42.80%
Gross Profit (ttm)N/A
EBITDA -122.89M
Net Income Avi to Common (ttm)-537.86M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)603.21M
Total Cash Per Share (mrq)1.23
Total Debt (mrq)1.1B
Total Debt/Equity (mrq)116.27%
Current Ratio (mrq)1.12
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-17.15M
Levered Free Cash Flow (ttm)-123.35M